论文部分内容阅读
美国西尔公司生产的 Cox- 2抑制剂 celecoxib( Celebrex)为首次在美国批准上市用于治疗家族性腺瘤息肉 ( FAP)的药物 ,它也将是世界范围内获准上市用于上述适应证的第一个药物。celecoxib用于息肉的治疗是在美国 FDA肿瘤药物咨询委员会推荐建议加快批准后一个星期被 FDA批准的?
Celecoxib (Celebrex), the Cox-2 inhibitor produced by the American company Silicone, is the first drug to be marketed for the treatment of familial adenomatous polyps (FAP) in the United States and will also be approved worldwide for use in the above indications A medicine Is celecoxib used in the treatment of polyps FDA approved a week after the recommendation of the FDA’s FDA Advisory Committee on Oncology?